Showing results (71-80 of 610) with videos related to

Sort By:
Pageof 61
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 17, 2015
Stepwise group sparse regression (SGSR): gene-set-based pharmacogenomic predictive models with stepwise selection of functional priorsIn Sock Jang, Rodrigo Dienstmann, Adam A Margolin, et al.
Cancer Discovery|November 5, 2014
Social interactomes for enabling research communitiesJustin Guinney, Rodrigo Dienstmann, Charles Ferté, et al.
British Journal of Cancer|July 24, 2024
COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancerNeil H Segal, Jeanne Tie, Scott Kopetz, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 20, 2015
Pharmacokinetic and pharmacodynamic evaluation of aflibercept for the treatment of colorectal cancerEnrique Sanz-Garcia, Tamara Saurí, Josep Tabernero, et al.
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|May 9, 2012
[Neuroendocrine tumors: the age of targeted therapies]Jaume Capdevila, Guillem Argilés, Nuria Mulet-Margalef, et al.
Advances in Clinical Chemistry|September 23, 2010
EGFR and KRAS in colorectal cancerBen Markman, Francisco Javier Ramos, Jaume Capdevila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2019
Impact of Prior Bevacizumab Treatment on VEGF-A and PlGF Levels and Outcome Following Second-Line Aflibercept Treatment: Biomarker Post Hoc Analysis of the VELOUR TrialEric Van Cutsem, Caroline Paccard, Marielle Chiron, et al.
Lancet (London, England)|December 7, 2020
Enhancing anti-tumour efficacy with immunotherapy combinationsFunda Meric-Bernstam, James Larkin, Josep Tabernero, et al.
Targeted Oncology|November 12, 2009
Targeted therapies in thyroid cancerJaume Capdevila, Jose Perez-Garcia, Gabriel Obiols, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2011
SEOM clinical guidelines for the treatment of pancreatic cancerCarlos Gómez-Martín, Manuel Hidalgo, Josep Tabernero, et al.
Pageof 61